glp-1 obesity drug news today september 2025 weight loss drugs leave users low on key nutrients, study finds GLP-1 Agonists: Using Semaglutide, Tirzepatide,

Published in 1981, this peptide consisted of 69 amino acids and was initially called glicentin (Thim, Moody)

It is important to note that randomized trials typically involve a highly selective group of individuals who do not accurately reflect the general population with T2DM

Semaglutide attenuates anxious and depressive-like behaviors and reverses the cognitive impairment in a type 2 diabetes mellitus mouse model via the microbiota-gut-brain axis

Lastly, as demonstrated by a large online survey, patients with T2DM generally have a positive attitude towards the option of a weekly-administered antidiabetic therapy rather than a daily one [74], especially when it involves a user-friendly device [75]

doi: 10.1016/j.cmet.2022.07.013 80 le RouxCWSteenOLucasKJStartsevaEUnseldAHennigeAM

Diabetes 2002;51 Suppl 3(S434442